Search research articles
Contact Us
Filters
Showing results (21-30 of 92) with videos related to
Page
of 10
Sort By:
Hepatology (Baltimore, Md.)
|
February 4, 2023
Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease
Ian A Rowe, Alina M Allen
Journal of Hepatology
|
August 8, 2016
Establishing the independence and clinical importance of non-alcoholic fatty liver disease as a risk factor for cardiovascular disease
C Ramu Chimakurthi, Ian A Rowe
Hepatology (Baltimore, Md.)
|
February 15, 2017
Patient understanding of hepatocellular carcinoma surveillance
Matthew A Goldsworthy, Ian A Rowe
JHEP Reports : Innovation in Hepatology
|
December 16, 2025
MELD 3.<i>i</i> and the case for continuous updating in liver allocation
Ian A Rowe, Juan G Abraldes
BMJ (Clinical Research Ed.)
|
November 15, 2011
Protease inhibitors for treatment of genotype 1 hepatitis C virus infection
Ian A Rowe, David J Mutimer
Gastroenterology
|
January 22, 2018
What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
Callum P Wood, Ian A Rowe
Gastroenterology
|
October 8, 2016
Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage
Tehreem Chaudhry, Audrey Dillon, Ian A Rowe
The American Journal of Gastroenterology
|
March 6, 2012
Appropriateness of hepatitis a vaccination in patients with hepatitis C
Ian A Rowe, Richard Parker, Diarmaid D Houlihan
Hepatology (Baltimore, Md.)
|
March 17, 2015
Is pentoxifylline still an option in severe alcoholic hepatitis?
Sarah A Townsend, Ian A Rowe, Ahmed M Elsharkawy
European Journal of Gastroenterology & Hepatology
|
November 20, 2020
High rates of ineligibility for participation in trials of new therapies in non-alcoholic steatohepatitis: a systematic review
Anna Roskilly, Jessica Shearer, Richard Parker, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 92) with videos related to
Sort By:
Page
of 10
Hepatology (Baltimore, Md.)
|
February 4, 2023
Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease
Ian A Rowe, Alina M Allen
Journal of Hepatology
|
August 8, 2016
Establishing the independence and clinical importance of non-alcoholic fatty liver disease as a risk factor for cardiovascular disease
C Ramu Chimakurthi, Ian A Rowe
Hepatology (Baltimore, Md.)
|
February 15, 2017
Patient understanding of hepatocellular carcinoma surveillance
Matthew A Goldsworthy, Ian A Rowe
JHEP Reports : Innovation in Hepatology
|
December 16, 2025
MELD 3.<i>i</i> and the case for continuous updating in liver allocation
Ian A Rowe, Juan G Abraldes
BMJ (Clinical Research Ed.)
|
November 15, 2011
Protease inhibitors for treatment of genotype 1 hepatitis C virus infection
Ian A Rowe, David J Mutimer
Gastroenterology
|
January 22, 2018
What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
Callum P Wood, Ian A Rowe
Gastroenterology
|
October 8, 2016
Uncertain Benefits of Simvastatin in the Treatment of Patients With Variceal Hemorrhage
Tehreem Chaudhry, Audrey Dillon, Ian A Rowe
The American Journal of Gastroenterology
|
March 6, 2012
Appropriateness of hepatitis a vaccination in patients with hepatitis C
Ian A Rowe, Richard Parker, Diarmaid D Houlihan
Hepatology (Baltimore, Md.)
|
March 17, 2015
Is pentoxifylline still an option in severe alcoholic hepatitis?
Sarah A Townsend, Ian A Rowe, Ahmed M Elsharkawy
European Journal of Gastroenterology & Hepatology
|
November 20, 2020
High rates of ineligibility for participation in trials of new therapies in non-alcoholic steatohepatitis: a systematic review
Anna Roskilly, Jessica Shearer, Richard Parker, et al.
Page
of 10